Remind me, was it late 2016, or in 2017 that Pravin Kaumaya entrusted his brilliant drug technology to Imugene to trial, and then bring to market?
I had a peep at the IMU 2013 AGM Report which contained the forecast for the Phase 3 trial commencement of HERR-vaxx in 2015, with commercialisation in 2016! I do remember my decision to invest in IMU was predicated on the success of the drug in the Phase 1 trial for breast cancer. I think we may have owned the 2 drugs for a combined 17 years now!!
Media Thread, page-11153
-
- There are more pages in this discussion • 4,547 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 5443565 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2171910 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |